Clinical Trials on Mantle Cell Lymphoma
Total 47056 results
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
BeiGeneRecruitingFollicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | B-cell MalignancyUnited States, Spain, Italy, Australia, France, Korea, Republic of, United Kingdom, Canada, Brazil, Georgia, Sweden, Germany, Moldova, Republic of
-
Mayo ClinicRecruitingWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Hematopoietic and Lymphoid System NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent... and other conditionsUnited States
-
Johnson & Johnson Private LimitedCompletedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-CellIndia
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
Marcela V. Maus, M.D.,Ph.D.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | CD20-Positive Neoplastic Cells Present | Refractory Mature B-Cell Non-Hodgkin LymphomaUnited States
-
Hospices Civils de LyonThe Lymphoma Academic Research OrganisationRecruitingMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Diffuse Large B Lymphoma (DLBCL) | Marginal Zone Lymphoma (MZL) | T-cell Lymphoma (T-NHL) | Hodgkin's Lymphoma (HL) | Burkitt Lymphoma (BL))France
-
University of WashingtonBristol-Myers SquibbActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma and other conditionsUnited States
-
CelgeneTerminatedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaUnited States, Spain, United Kingdom, Germany, France, Czechia, Israel, Italy, Poland, Portugal, Puerto Rico, Russian Federation
-
PfizerCompletedNon-Hodgkin's LymphomaKorea, Republic of, Australia, Czechia, United States, Romania, Germany, France, Poland, Italy, Russian Federation, Serbia
-
Weill Medical College of Cornell UniversityCompleted
-
Charite University, Berlin, GermanyWyeth is now a wholly owned subsidiary of Pfizer; Mundipharma K.K.WithdrawnMantle Cell LymphomaGermany
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingMantle Cell LymphomaUnited States
-
Dalian Medical UniversityNot yet recruiting
-
Shanxi Province Cancer HospitalNot yet recruiting
-
C. Babis AndreadisEli Lilly and Company; Genentech, Inc.; Adaptive BiotechnologiesNot yet recruitingMantle Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Fondazione Italiana Linfomi - ETSRecruiting
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingMantle Cell LymphomaUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Israel, Turkey, Ukraine, Japan, Canada, Greece, Korea, Republic of, Netherlands, Brazil, Russian Federation, Puerto Rico, Australia, I... and more
-
Fondazione Italiana Linfomi - ETSActive, not recruiting
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Germany, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
SCRI Development Innovations, LLCAcerta Pharma, LLCCompletedMantle Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationActive, not recruiting
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
The Lymphoma Academic Research OrganisationActive, not recruitingMantle Cell LymphomaFrance, Spain, Belgium, Netherlands, Germany, Poland, Portugal
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Eli Lilly and CompanyCompleted
-
Guangzhou Lupeng Pharmaceutical Company LTD.Completed
-
Weill Medical College of Cornell UniversityCelgeneCompleted
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedMantle Cell LymphomaCanada
-
Zhejiang DTRM BiopharmaCompleted
-
Fondazione Italiana Linfomi ONLUSActive, not recruiting
-
Fondazione Italiana Linfomi ONLUSCompleted
-
Samsung Medical CenterUnknownMantle Cell LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
University of Wisconsin, MadisonCompleted
-
GlaxoSmithKlineCompleted
-
Weill Medical College of Cornell UniversityPfizer; Millennium Pharmaceuticals, Inc.TerminatedMantle Cell LymphomaUnited States
-
Lymphoma Study AssociationTerminated
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaFrance, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Colombia, Portugal, Ukraine, Canada, Netherlands, Sweden, Korea, Republic of, Chile, Brazil, Russian Federation, Hungary, Ireland, Mexico, Czechia
-
Prof. Dr. M. Dreyling (co-chairman)ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...UnknownMantle Cell LymphomaFrance, Germany
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaUnited States, France, United Kingdom, Belgium, Spain, Israel, Puerto Rico, Poland, Russian Federation
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.; Janssen, LPCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; BiogenCompletedMantle Cell LymphomaUnited States